Imaging Heart Changes With a Radioactive Tracer in Heart Disease
Tests a radioactive tracer scan of the heart in adults with aortic stenosis or diabetes.
Key facts
- Who runs it
- Massachusetts General Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Imaging Histone Deacetylase in the Heart
- Status
- Recruiting
- People taking part
- 96 people, planned
- Started
- 7 Sept 2018
- Planned end
- 1 Sept 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 11C-Martinostat
- PET-MRI
- Record updated
- 22 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for three groups of adults: healthy volunteers, people with diabetes, and people with aortic stenosis. It tests a heart imaging method with 11C-Martinostat using PET-MRI scans.
- Age
- 18-85 years
- Sex
- All sexes can join.
- Disease stage
- Healthy volunteers: no known medical disease and no cardiovascular disease. Diabetes: a diabetes diagnosis, and a heart ultrasound in the last 12 months showing no thickened left heart wall and no signs of heart failure with preserved ejection fraction. Aortic stenosis: a heart ultrasound or heart MRI in the last 12 months showing a thickened left heart wall and degenerative calcific aortic stenosis.
Main reasons for not taking part
- Known reason that an MRI scan cannot be done
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Group 1: Healthy Volunteers (n = 30)
- Healthy adults with no known history of medical disease
- Age 18-85 years
- No history cardiovascular disease
- Ability to provide informed consent; Group 2: Patients with Diabetes (n = 16)
- Age 18-85 years
- Diagnosis of diabetes
- Echocardiogram within last 12 months showing no evidence of left ventricular hypertrophy or hemodynamic findings consistent with heart failure with preserved ejection fraction
- Ability to provide informed consent; Group 3: Patients with Aortic Stenosis (n = 50)
- Age 18-85 years
- Echocardiogram or cardiac MRI scan within last 12 months documenting left ventricular hypertrophy and degenerative calcific aortic stenosis
- Ability to provide informed consent
Who cannot take part
- Known contraindication to MRI
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Where in United States
- Massachusetts General HospitalBoston, United StatesContact: David Sosnovik, MDTaking people
About the trial
What the trial wants to find out
The overall goal of this PET-MR imaging trial is to evaluate 11C-Martinostat, a histone deacetylase targeted radioligand, in patients with aortic stenosis, individuals with diabetes, and healthy volunteers.
The 3 groups in the trial
- Healthy SubjectsExisting treatment, for comparison
Healthy subjects will receive an IV injection of 11C-Martinostat and undergo simultaneous PET-MRI.
Treatment: 11C-Martinostat and PET-MRI
- Diabetes Patient SubjectsExisting treatment, for comparison
Patient subjects with diabetes will receive an IV injection of 11C-Martinostat and undergo simultaneous PET-MRI.
Treatment: 11C-Martinostat and PET-MRI
- Aortic Stenosis Patient SubjectsTreatment being tested
Patient subjects with aortic stenosis will receive an IV injection of 11C-Martinostat and undergo simultaneous PET-MRI before and after transcatheter valve replacement.
Treatment: 11C-Martinostat and PET-MRI
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Imaging of Histone Deacetylase in the Heart
- Plain-language title
- Imaging Heart Changes With a Radioactive Tracer in Heart DiseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT03549559, who can take part
- Record updated
- 22 December 2025